Do antidepressants lower the prevalence of lithium-associated hypernatremia in the elderly? A retrospective study

Canadian Geriatrics Journal

Volumn 16, Issue 2, 2013, Pages 38-42

  Rej, Soham ^a   Looper, Karl ^a,b   Segal, Marilyn ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Diabetes insipidus; Geriatric; Lithium; Psychopharmacology; Renal effects

Indexed keywords

EID: 84903394429     PISSN: None     EISSN: 19258348     Source Type: Journal    
DOI: 10.5770/cgj.16.50     Document Type: Article

References (14)

1. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10(5):329-45.
2. Bendz H, Aurell M, Balldin J, et al. Kidney damage in longterm lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant. 1994;9(9):1250-54.
3. Rej S, Herrmann N, Shulman K. The effects of lithium on renal function in older adults-a systematic review [Review]. J Geriatr Psychiatry Neurol. 2012;25(1):51-61.
4. Jeffery J, Ayling RM, McGonigle RJ. Successful rescue of severe hypernatraemia (196 mmol/L) by treatment with hypotonic fluid. Ann Clin Biochem. 2007;44(Pt 5):491-94.
5. Mukhopadhyay D, Gokulkrishnan L, Mohanaruban K. Lithium-induced nephrogenic diabetes insipidus in older people. Age Ageing. 2001;30(4):347-50.
6. Liu BA, Mittmann N, Knowles SR, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. CMAJ. 19961;155(5):519-27.
7. Koelkebeck K, Domschke K, Zwanzger P, et al. A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine. World J Biol Psychiatry. 2009;10 (4 Pt 2):609-11.
8. Garofeanu CG, Weir M, Rosas-Arellano MP, et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis. 2005;45(4):626-37.
9. Adrogue HJ, Madias NE. Hypernatremia [Review]. N Engl J Med. 2000;342(21):1581-89.
10. Wilkinson TJ, Begg EJ, Winter AC, et al. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47(2):211-17.
11. Padfield PL, Park SJ, Morton JJ, et al. Plasma levels of antidiuretic hormone in patients receiving prolonged lithium therapy. Br J Psychiatry. 1977;130:144-47.
12. Moyses ZP, Nakandakari FK, Magaldi AJ. Fluoxetine effect on kidney water reabsorption. Nephrol Dial Transplant. 2008;23(4):1173-78.
13. R oxanas M, Hibbert E, Field M. Venlafaxine hyponatraemia: incidence, mechanism and management. Aust N Z J Psychiatry. 2007;41(5):411-18.
14. Chassagne P, Druesne L, Capet C, et al. Clinical presentation of hypernatremia in elderly patients: a case control study. J Am Geriatr Soc. 2006;54(8):1225-30.